MarketScan data

You have access
Risk of Cancer Following Lumbar Fusion Surgery With Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2): An Analysis Using a Commercially Insured Patient Population
GREGORY S. COOPER and TZUYUNG DOUG KOU

International Journal of Spine Surgery April 2018, 12 (2) 260-268; DOI: https://doi.org/10.14444/50323